An Upper Bound for the Capacity of Amplitude-Constrained Scalar AWGN Channel

This paper slightly improves the upper bound in Thangaraj et al. for the capacity of the amplitude-constrained scalar AWGN channel. This improvement makes the upper bound within 0.002 bits of the capacity for $\frac{E_b}{N_0}\leq 2.5$ dB

Rate Splitting for MIMO Wireless Networks: A Promising PHY-Layer Strategy for LTE Evolution

MIMO processing plays a central part towards the recent increase in spectral and energy efficiencies of wireless networks. MIMO has grown beyond the original point-to-point channel and nowadays refers to a diverse range of centralized and distributed deployments. The fundamental bottleneck towards enormous spectral and energy efficiency benefits in multiuser MIMO networks lies in a huge demand for accurate channel state information at the transmitter (CSIT). This has become increasingly difficult to satisfy due to the increasing number of antennas and access points in next generation wireless networks relying on dense heterogeneous networks and transmitters equipped with a large number of antennas. CSIT inaccuracy results in a multi-user interference problem that is the primary bottleneck of MIMO wireless networks. Looking backward, the problem has been to strive to apply techniques designed for perfect CSIT to scenarios with imperfect CSIT. In this paper, we depart from this conventional approach and introduce the readers to a promising strategy based on rate-splitting. Rate-splitting relies on the transmission of common and private messages and is shown to provide significant benefits in terms of spectral and energy efficiencies, reliability and CSI feedback overhead reduction over conventional strategies used in LTE-A and exclusively relying on private message transmissions. Open problems, impact on standard specifications and operational challenges are also discussed.Comment: accepted to IEEE Communication Magazine, special issue on LTE Evolutio

Gaussian multiple access channels with one-bit quantizer at the receiver

The capacity region of a two-transmitter Gaussian multiple access channel (MAC) under average input power constraints is studied, when the receiver employs a zero-threshold one-bit analogue-to-digital converter (ADC). It is proven that the input distributions of the two transmitters that achieve the boundary points of the capacity region are discrete. Based on the position of a boundary point, upper bounds on the number of the mass points of the corresponding distributions are derived. Furthermore, a lower bound on the sum capacity is proposed that can be achieved by time division with power control. Finally, inspired by the numerical results, the proposed lower bound is conjectured to be tight

An operational information decomposition via synergistic disclosure

Abstract: Multivariate information decompositions hold promise to yield insight into complex systems, and stand out for their ability to identify synergistic phenomena. However, the adoption of these approaches has been hindered by there being multiple possible decompositions, and no precise guidance for preferring one over the others. At the heart of this disagreement lies the absence of a clear operational interpretation of what synergistic information is. Here we fill this gap by proposing a new information decomposition based on a novel operationalisation of informational synergy, which leverages recent developments in the literature of data privacy. Our decomposition is defined for any number of information sources, and its atoms can be calculated using elementary optimisation techniques. The decomposition provides a natural coarse-graining that scales gracefully with the system’s size, and is applicable in a wide range of scenarios of practical interest

Adiponectin Expression from Human Adipose Tissue: Relation to Obesity, Insulin Resistance, and Tumor Necrosis Factor-α Expression

Adiponectin is a 29-kDa adipocyte protein that has been linked to the insulin resistance of obesity and lipodystrophy. To better understand the regulation of adiponectin expression, we measured plasma adiponectin and adipose tissue adiponectin mRNA levels in nondiabetic subjects with varying degrees of obesity and insulin resistance. Plasma adiponectin and adiponectin mRNA levels were highly correlated with each other (r = 0.80, P \u3c 0.001), and obese subjects expressed significantly lower levels of adiponectin. However, a significant sex difference in adiponectin expression was observed, especially in relatively lean subjects. When men and women with a BMI2were compared, women had a twofold higher percent body fat, yet their plasma adiponectin levels were 65% higher (8.6 ± 1.1 and 14.2 ± 1.6 μg/ml in men and women, respectively; P \u3c 0.02). Plasma adiponectin had a strong association with insulin sensitivity index (SI) (r = 0.67, P \u3c 0.0001, n = 51) that was not affected by sex, but no relation with insulin secretion. To separate the effects of obesity (BMI) from SI, subjects who were discordant for SI were matched for BMI, age, and sex. Using this approach, insulin-sensitive subjects demonstrated a twofold higher plasma level of adiponectin (5.6 ± 0.6 and 11.2 ± 1.1 μg/ml in insulin-resistant and insulin-sensitive subjects, respectively; P \u3c 0.0005). Adiponectin expression was not related to plasma levels of leptin or interleukin-6. However, there was a significant inverse correlation between plasma adiponectin and tumor necrosis factor (TNF)-α mRNA expression (r = -0.47, P \u3c 0.005), and subjects with the highest levels of adiponectin mRNA expression secreted the lowest levels of TNF-α from their adipose tissue in vitro. Thus, adiponectin expression from adipose tissue is higher in lean subjects and women, and is associated with higher degrees of insulin sensitivity and lower TNF-α expression

An operational information decomposition via synergistic disclosure

Abstract Multivariate information decompositions hold promise to yield insight into complex systems, and stand out for their ability to identify synergistic phenomena. However, the adoption of these approaches has been hindered by there being multiple possible decompositions, and no precise guidance for preferring one over the others. At the heart of this disagreement lies the absence of a clear operational interpretation of what synergistic information is. Here we fill this gap by proposing a new information decomposition based on a novel operationalisation of informational synergy, which leverages recent developments in the literature of data privacy. Our decomposition is defined for any number of information sources, and its atoms can be calculated using elementary optimisation techniques. The decomposition provides a natural coarse-graining that scales gracefully with the system’s size, and is applicable in a wide range of scenarios of practical interest.</jats:p

Pectic acid effects on prolactin secretion in GH3/B6 rat pituitary cell line

Background: Pectic acid extracted from plants increases the secretion of prolactin (PRL) when injected intravenously into ewes or fed to rats. Fragments of ewe hypophysis and lactating rabbit mammary gland incubated in vitro in the presence of pectic acid secreted more PRL and caseins compared to the controls. However, it is not known whether pectic acid directly stimulates PRL secretion in pituitary or interference of factors from hypophysis is required for this process. Methods: GH3/B6 cells, a clonal strain of rat pituitary, were cultured and incubated with pectic acid (2.5-100 μg/mL). The integrity of cells was examined under pectic acid treatment microscopically. Controls or pectic acid treated cells were assayed for their ability to produce PRL. The PRL was assayed by Western-blotting and Radioimmunoassay. Results: pectic acid did not have any significant effect on the viability of cells. After being incubated with pectic acid, the cells started to become circular and protuberant shape. The maximum stimulation and PRL secretion occurred at 100 μg/mL concentration within 30 min of incubation with pectic acid. Conclusion: pectic acid could stimulate the release of PRL in GH3/B6 cells in the short-term incubation. This result suggested that pectic acid is a nontoxic agent that could directly stimulate PRL secretion in pituitary cells without any interference of hypophysis

Enhancing LTE with Cloud-RAN and Load-Controlled Parasitic Antenna Arrays

Cloud radio access network systems, consisting of remote radio heads densely distributed in a coverage area and connected by optical fibers to a cloud infrastructure with large computational capabilities, have the potential to meet the ambitious objectives of next generation mobile networks. Actual implementations of C-RANs tackle fundamental technical and economic challenges. In this article, we present an end-to-end solution for practically implementable C-RANs by providing innovative solutions to key issues such as the design of cost-effective hardware and power-effective signals for RRHs, efficient design and distribution of data and control traffic for coordinated communications, and conception of a flexible and elastic architecture supporting dynamic allocation of both the densely distributed RRHs and the centralized processing resources in the cloud to create virtual base stations. More specifically, we propose a novel antenna array architecture called load-controlled parasitic antenna array (LCPAA) where multiple antennas are fed by a single RF chain. Energy- and spectral-efficient modulation as well as signaling schemes that are easy to implement are also provided. Additionally, the design presented for the fronthaul enables flexibility and elasticity in resource allocation to support BS virtualization. A layered design of information control for the proposed end-to-end solution is presented. The feasibility and effectiveness of such an LCPAA-enabled C-RAN system setup has been validated through an over-the-air demonstration

A Novel Role of Peripheral Corticotropin-Releasing Hormone (CRH) on Dermal Fibroblasts

Corticotropin-releasing hormone, or factor, (CRH or CRF) exerts important biological effects in multiple peripheral tissues via paracrine/autocrine actions. The aim of our study was to assess the effects of endogenous CRH in the biology of mouse and human skin fibroblasts, the primary cell type involved in wound healing. We show expression of CRH and its receptors in primary fibroblasts, and we demonstrate the functionality of fibroblast CRH receptors by induction of cAMP. Fibroblasts genetically deficient in Crh (Crh−/−) had higher proliferation and migration rates and compromised production of IL-6 and TGF-β1 compared to the wildtype (Crh+/+) cells. Human primary cultures of foreskin fibroblasts exposed to the CRF1 antagonist antalarmin recapitulated the findings in the Crh−/− cells, exhibiting altered proliferative and migratory behavior and suppressed production of IL-6. In conclusion, our findings show an important role of fibroblast-expressed CRH in the proliferation, migration, and cytokine production of these cells, processes associated with the skin response to injury. Our data suggest that the immunomodulatory effects of CRH may include an important, albeit not explored yet, role in epidermal tissue remodeling and regeneration and maintenance of tissue homeostasis

Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes

BACKGROUND: Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease. METHODS: In this randomized, double-blind study, we assigned 14,671 patients to add either sitagliptin or placebo to their existing therapy. Open-label use of antihyperglycemic therapy was encouraged as required, aimed at reaching individually appropriate glycemic targets in all patients. To determine whether sitagliptin was noninferior to placebo, we used a relative risk of 1.3 as the marginal upper boundary. The primary cardiovascular outcome was a composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. RESULTS: During a median follow-up of 3.0 years, there was a small difference in glycated hemoglobin levels (least-squares mean difference for sitagliptin vs. placebo, -0.29 percentage points; 95% confidence interval [CI], -0.32 to -0.27). Overall, the primary outcome occurred in 839 patients in the sitagliptin group (11.4%; 4.06 per 100 person-years) and 851 patients in the placebo group (11.6%; 4.17 per 100 person-years). Sitagliptin was noninferior to placebo for the primary composite cardiovascular outcome (hazard ratio, 0.98; 95% CI, 0.88 to 1.09; P<0.001). Rates of hospitalization for heart failure did not differ between the two groups (hazard ratio, 1.00; 95% CI, 0.83 to 1.20; P = 0.98). There were no significant between-group differences in rates of acute pancreatitis (P = 0.07) or pancreatic cancer (P = 0.32). CONCLUSIONS: Among patients with type 2 diabetes and established cardiovascular disease, adding sitagliptin to usual care did not appear to increase the risk of major adverse cardiovascular events, hospitalization for heart failure, or other adverse events